FDA approves generic mifepristone amid controversy; critics say restrictions limit access, while others push to normalize abortion.
A Louisiana judge declined to block telehealth prescriptions for mifepristone, citing ongoing FDA reviews. The case highlights tensions between state bans and federal regulations, with legal challenges and political implications ongoing as anti-abortion groups push for restrictions.